Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-006009)

Filing Details

Accession Number:: 0001209191-19-006009
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-01-30 16:29:51
Reporting Period:: 2019-01-28

Accepted Time:: 2019-01-30 16:29:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1445283	Proteostasis Therapeutics Inc.	PTI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1661335	Shun Po Lee	C/O Proteostasis Therapeutics, Inc. 80 Guest Street, Suite 500 Boston MA 02135	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-01-28	1,600	$3.00	3,024	No	4	S	Direct
Common Stock	Disposition	2019-01-29	712	$3.00	2,312	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Includes 712 shares acquired on June 30, 2018 and 2,312 shares acquired on December 31, 2018, in each case pursuant to PTI's 2016 Employee Stock Purchase Plan.